---
title: "Fresh Tracks Therapeutics (FRTX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/FRTX.US/norm.md"
symbol: "FRTX.US"
name: "Fresh Tracks Therapeutics"
parent: "https://longbridge.com/en/quote/FRTX.US.md"
datetime: "2026-03-13T22:40:15.950Z"
locales:
  - [en](https://longbridge.com/en/quote/FRTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/FRTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/FRTX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/FRTX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/FRTX.US/norm.md)


# Fresh Tracks Therapeutics (FRTX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2071 | 0.3225 | -0.3867 | -1.14 | -1.50 |
| ROE | -47.44% | 80.54% | -102.32% | -200.52% | -196.64% |
| Revenue | 0.0000 | 7.94M | 53000.00 | 9000.00 | 2.05M |
| Net income | -1.24M | 1.91M | -2.28M | -4.28M | -4.53M |

## Balance Sheet (USD)

| Indicator | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| --- | --- | --- | --- | --- | --- |
| A&L | 11.59M | 13.06M | 9.84M | 11.97M | 10.27M |
| Leverage | 1.17 | 1.19 | 1.23 | 1.21 | 1.43 |
| BVPS | 1.66 | 1.85 | 1.35 | 1.67 | 2.38 |
| Turnover | 0.7326 | 0.7312 | 0.1833 | 0.4189 | 0.3473 |

## Cash Flow Statement (USD)

| Indicator | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.12M | 3.08M | -1.82M | -4.49M | -2.58M |
| Investing CF | - | - | - | - | 0.0000 |
| Financing CF | -28000.00 | -10000.00 | 0.0000 | 6.57M | 8000.00 |
| Free CF | -898500.00 | 2.17M | -1.01M | -2.93M | -931625.00 |